Annual CFF
$4.96 M
-$220.57 M-97.80%
December 31, 2022
Summary
- As of February 10, 2025, GRCL annual cash flow from financing activities is $4.96 million, with the most recent change of -$220.57 million (-97.80%) on December 31, 2022.
- During the last 3 years, GRCL annual CFF has fallen by -$52.19 million (-91.32%).
Performance
GRCL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
N/A
September 30, 2023
Summary
- GRCL quarterly cash flow from financing activities is not available.
Performance
GRCL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 30, 2023
Summary
- GRCL TTM cash flow from financing activities is not available.
Performance
GRCL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GRCL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.8% | - | - |
| 3 y3 years | -91.3% | - | - |
| 5 y5 years | -76.3% | - | - |
GRCL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.8% | at low | ||||
| 5 y | 5-year | -97.8% | at low | ||||
| alltime | all time | -97.8% | at low |
Gracell Biotechnologies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.28 M(-147.4%) | -$2.28 M(-147.4%) |
| Dec 2022 | $4.96 M(-97.8%) | - | - |
| Jun 2022 | - | $4.81 M(-97.8%) | $4.81 M(-97.9%) |
| Dec 2021 | $225.53 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $223.69 M(+2345.4%) | $232.84 M(+2445.4%) |
| Dec 2020 | $109.62 M(+91.8%) | - | - |
| Sep 2020 | - | $9.15 M | $9.15 M |
| Dec 2019 | $57.16 M(+172.4%) | - | - |
| Dec 2018 | $20.98 M | - | - |
FAQ
- What is Gracell Biotechnologies annual cash flow from financing activities?
- What is the all time high annual CFF for Gracell Biotechnologies?
- What is Gracell Biotechnologies annual CFF year-on-year change?
- What is the all time high quarterly CFF for Gracell Biotechnologies?
- What is the all time high TTM CFF for Gracell Biotechnologies?
What is Gracell Biotechnologies annual cash flow from financing activities?
The current annual CFF of GRCL is $4.96 M
What is the all time high annual CFF for Gracell Biotechnologies?
Gracell Biotechnologies all-time high annual cash flow from financing activities is $225.53 M
What is Gracell Biotechnologies annual CFF year-on-year change?
Over the past year, GRCL annual cash flow from financing activities has changed by -$220.57 M (-97.80%)
What is the all time high quarterly CFF for Gracell Biotechnologies?
Gracell Biotechnologies all-time high quarterly cash flow from financing activities is $223.69 M
What is the all time high TTM CFF for Gracell Biotechnologies?
Gracell Biotechnologies all-time high TTM cash flow from financing activities is $232.84 M